Eagle Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
10,455.60
34,869.00
79,083.00
52,820.00
114,657.00
78,791
Total Accounts Receivable
5,124.20
11,956.00
26,267.00
42,194.00
53,821.00
66,486
Inventories
-
1,242.00
15,042.00
2,739.00
5,118.00
8,304
Other Current Assets
1,902.70
1,640.00
1,865.00
11,357.00
15,101.00
10,263
Total Current Assets
17,482.40
49,707.00
122,257.00
109,110.00
188,697.00
163,844
Net Property, Plant & Equipment
402.30
342.00
2,205.00
3,316.00
6,820.00
2,397
Intangible Assets
-
-
-
73,115.00
63,065.00
57,846
Other Assets
217.90
45.00
143.00
136.00
124.00
694
Total Assets
18,102.60
50,094.00
124,605.00
214,320.00
273,110.00
239,290
ST Debt & Current Portion LT Debt
-
-
-
-
4,875.00
Accounts Payable
1,192.60
3,501.00
3,857.00
14,716.00
11,981.00
Other Current Liabilities
13,149.20
18,685.00
30,405.00
26,249.00
30,446.00
Total Current Liabilities
14,341.80
22,186.00
34,262.00
40,965.00
47,302.00
Long-Term Debt
-
-
-
-
42,905.00
Provision for Risks & Charges
-
-
-
22,129.00
709.00
Deferred Taxes
-
-
-
28,643.00
11,354.00
Total Liabilities
14,341.80
22,186.00
34,262.00
63,094.00
93,966.00
Common Equity (Total)
87,929.00
27,908.00
90,343.00
151,226.00
179,144.00
Total Shareholders' Equity
3,760.80
27,908.00
90,343.00
151,226.00
179,144.00
Total Equity
3,760.80
27,908.00
90,343.00
151,226.00
179,144.00
Liabilities & Shareholders' Equity
18,102.60
50,094.00
124,605.00
214,320.00
273,110.00
Preferred Stock (Carrying Value)
91,689.80
-
-
-
-
About Eagle Pharmaceuticals
View Profile
